Navigation Links
VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S.
Date:7/16/2009

al. (2009). Effect of Tramiprosate in Patients with

Mild-to-Moderate Alzheimer's Disease: Exploratory Analyses of the MRI

Sub-group of the Alphase Study. Journal of Nutrition, Health and Aging,

Volume 13, Number 6/June 2009, 550-557.

Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond BELLUS Health Inc.'s control. Such risks include but are not limited to: the impact of general economic conditions, general conditions in the pharmaceutical and/or nutraceutical industry, changes in the regulatory environment in the jurisdictions in which the BELLUS Health Group does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation, that actual results may vary once the final and quality-controlled verification of data and analyses has been completed, as well as other risks disclosed in public filings of BELLUS Health Inc. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. The reader should not place undue reliance, if any, on any forward-looking statements included in this news release. These statements speak only as of the date made and BELLUS Health Inc. is under no obligation and disavows any intention to update or revise such statements as a result of any event, circumstances or otherwise, unless required by applicable legislation or regulation. Please see the Annual Information Form of BELLUS Health Inc. for further risk factors that might affect the BELLUS Health Group and its business.

CONTACT: Michelle Stein, Specialist, Corporate Communications, (450) 680-4573,

SOURCE BELLUS HEALTH INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration
3. A Random Act of Kindness Changes a Familys Life Forever as Alexzander Prados Wish to Walk is Granted at Abilities Expo
4. Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
5. Vision Pharma Is Granted Motion for Judgment
6. Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
7. Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
8. Hahnemann University Hospital Granted Surgical Fellowship Training Program for Pelvic Floor Disorders
9. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
10. Rib-X Granted Key Antibiotic Patent in China
11. MonoSol Rx Granted U.S. Article of Manufacture Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Irvine, CA (PRWEB) March 27, 2015 ... nation’s leading providers of business support services to dental ... opening of an affiliated Castle Dental office ... Lake Blvd. Hendersonville, TN 37075, this new Castle Dental ... they can receive the latest in comprehensive, quality dental ...
(Date:3/27/2015)... March 27, 2015 “ VXi BlueParott ... its monthly Tech Report, which features the latest and ... technology expert and special reporter for NewsWatch, conducted the ... advanced noise-cancelling headset, eliminating 90% of ambient noise. , ... texts and emails are important to any professional, voice ...
(Date:3/27/2015)... The Florida Center for Brain Tumor Research (FCBTR), ... $350,000 to support brain cancer research at three leading ... and H. Lee Moffitt Cancer Center and Research Institute. ... path and potential to provide meaningful improvements in treatment ... The awards fund research in areas on the cutting ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... a Quaker-based, philanthropic, grant-making foundation committed to raising ... behavioral healthcare is delivered. , The Scattergood Foundation ... advance Behavioral Health Policy and Practice through the ... SoundsLikeIBS Program App is designed to guide ...
(Date:3/26/2015)... 2015 Elfster.com, the top-rated Secret Santa ... bucket list generator capabilities to its leading Secret Santa ... a list that one creates of things to do ... of the same name. Nowadays many millennials are ... their summer achievements. , "We are greatly expanding our ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2
... , , , ... (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering ... progress and reported financial results for the three months and six months ... programs continue to progress, including the recent initiation of a Phase 2 ...
... , , WESTERVILLE, Ohio, July 28 ... level, but how can they do this while preserving a normal ... can maintain precise glycemic control and lessen the long-term effects of ... their supplies, health insurers often turn to independent review organizations (IROs) ...
... , , , ... today that it has raised an additional $12 million to ... The company is discovering and developing biotherapeutics to treat ... metabolic disorders. Founded in 2006 by Paul Schimmel, a ...
... , , GAINESVILLE, Fla., July 28 ... electronic cigarette products last week, the administration only tested two different brands. ... they are made by the two manufacturers currently suing the FDA in ... comparison to the toxins and carcinogens contained in tobacco cigarettes, the FDA,s ...
... , , LONDON, July ... started to integrate many IT-based ancillary systems such as EMR, ... service-oriented business, in which IT systems have accelerated healthcare practices. ... and radiologists is creating a challenge for hospitals. A huge ...
... , , , BEVERLY ... with a vastly changed economy, plastic surgery is now ... customer can easily find bargain prices without compromising quality. Here are a ... complete version of this article an be found at http://drsimoni.com/wordpress/ ...
Cached Medicine News:Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 2Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 3Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 4Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 5Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 6Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 7Health News:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 8Health News:Determining Insulin Pump Need for Diabetics 2Health News:aTyr Pharma Raises an Additional $12 Million 2Health News:aTyr Pharma Raises an Additional $12 Million 3Health News:Ecigarettesnational.com Says Claim by FDA and Other Health Organizations Intentionally Misleading 2Health News:Ecigarettesnational.com Says Claim by FDA and Other Health Organizations Intentionally Misleading 3Health News:Radiology Informatics: Frost & Sullivan Examines the Next Big Wave in Medicine 2Health News:Ten Secrets for Getting High Quality Plastic Surgery at More Affordable Prices 2Health News:Ten Secrets for Getting High Quality Plastic Surgery at More Affordable Prices 3
(Date:3/27/2015)... March 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... of its previously announced registered offering of common shares ... "Offering"). Pursuant to the Offering, the Company issued 7,286,432 ... for aggregate gross proceeds of approximately $1.45 billion. On ... Securities and Exchange Commission a final prospectus supplement to ...
(Date:3/27/2015)... NORTH HOLLYWOOD, Calif. , March 27, 2015 /PRNewswire/ ... quality of life of myeloma patients while working toward ... Brian Higgins (D-NY) for introducing a federal resolution ... month of March 2015 as "National Multiple Myeloma Awareness ... people living with myeloma worldwide, and more than 110,000 ...
(Date:3/27/2015)... March 27, 2015  Johnson & Johnson (NYSE: JNJ ... a.m. (Eastern Time) on Thursday, April 23, 2015, from the ... Investors and other interested parties may access the ... website at www.jnj.com and clicking on the webcast ... will be made available a few hours after the live ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... ADD NEW CENTERS AND TO ... INCREASE AWARENESS AMONG CARDIOLOGISTS, PLEASANTON, Calif., April 21 ... device-based mechanical,circulatory support therapies to save, support and restore failing ... PMA (PreMarket,Approval) application, allowing the use of its HeartMate II ...
... EDISON, N.J., April 21 Nostrum, a ... today that it has,successfully completed its early, ... protein currently known as SMRX11. Nostrum,s,Symmetrix subsidiary, ... drug under Nostrum,s license from the Institute ...
Cached Medicine Technology:Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 2Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 3Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 4Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 5Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: